Author:
Khan Arshiya,Singh Adarshlata,Madke Bhushan,Bhatt Drishti M,Jangid Shivani D
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Pemphigus vulgaris;Porro AM;An Bras Dermatol,2019
2. B-cell targeted therapy of pemphigus;Yamagami J;J Dermatol,2023
3. Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic;de Sèze J;Front Immunol,2023
4. Clinical Trials. A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate (SCORE). (2015). Accessed: January 22, 2024: https://classic.clinicaltrials.gov/ct2/show/NCT00578305.
5. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial;Merrill JT;Arthritis Rheum,2010